Conference Description
The 2019 GRC on Catecholamines will focus on cutting-edge developments in catecholamine research from a broad range of approaches, from molecular biology to cellular physiology, and from computational neuroscience to behavior. One of the characteristics of the field is that neuronal systems using catecholamines have much in common, although investigators who focus on particular catecholamines or on different actions of the same catecholamine are often unaware of complementary aspects of catecholamine research. It is increasingly apparent that continued progress will require integrated approaches in studies of catecholamine biology, function and dysfunction. Thus, molecular biologists are being drawn to more integrated systems approaches and behavioral biologists are exploiting many molecular approaches, and many are using increasingly sophisticated quantitative and computational approaches. In particular, the development of cell-type-specific targeting approaches in recent years has permitted much more detailed and specific approaches to understanding catecholamine function, revealing new complexities in organization and function, an important focus of the 2019 sessions. The past years have also witnessed a tremendous advance in our understanding of neuropsychiatric and neurological disorders, including drug abuse, affective disorders, and diseases with catecholamine neuron degeneration such as Parkinson's and Alzheimer's. Sophisticated behavioral measures combined with elegant molecular, cellular and systems approaches, have revealed important conserved mechanisms at the cellular, circuit, and behavioral levels across the phylogenetic scale from drosophila to humans. These studies provide new insights into modulation of innate and learned behavior. We plan to highlight these new advances, providing a unique opportunity to discuss recent progress in the understanding of catecholamine system contributions to health and disease. To achieve these goals, the 2019 conference will include researchers at the forefront of catecholamine-related research, both junior and senior, presenting primarily new, unpublished research encompassing basic mechanisms of catecholamine neurotransmission, integrated approaches to understand anatomy, physiology and behavior, and studies of neurological and psychiatric pathology and treatment.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by April 11, 2019. Please check back for updates.
Keynote Session: Heterogeneity in the Midbrain: From Cell Type Identification to Function
Discussion Leaders
-
Garret Stuber (University of North Carolina at Chapel Hill, USA)
Speakers
-
Marisela Morales (National Institute on Drug Abuse, NIH, USA)
Catecholamine Cellular and Circuit Heterogeneity
Discussion Leaders
-
Lindsay Schwarz (St. Jude Children's Research Hospital, USA)
Speakers
-
Erin Calipari (Vanderbilt University School of Medicine, USA)
-
Oxana Eschenko (Max Planck Institute for Biological Cybernetics, Germany)
-
Patricia Jensen (National Institute of Environmental Health Sciences, NIH, USA)
-
Stephan Lammel (University of California, Berkeley, USA)
-
Talia Lerner (Northwestern University, USA)
-
Mario Penzo (National Institute of Mental Health, NIH, USA)
Catecholamines and Neurotransmission
Discussion Leaders
-
Veronica Alvarez (National Institute on Alcohol Abuse and Alcoholism, NIH, USA)
Speakers
-
Sara Jones (Wake Forest School of Medicine, USA)
-
Pascal Kaeser (Harvard Medical School, USA)
-
Colleen McClung (University of Pittsburgh, USA)
-
Lin Tian (University of California, Davis, USA)
Catecholamines in Neurological and Psychiatric Disorders
Discussion Leaders
-
Meaghan Creed (Washington University School of Medicine, USA)
Speakers
-
Gul Dolen (Johns Hopkins University, USA)
-
Aryn Gittis (Carnegie Mellon University, USA)
-
Thomas Hnasko (University of California, San Diego, USA)
-
Mary Kay Lobo (University of Maryland School of Medicine, USA)
-
David Weinshenker (Emory University School of Medicine, USA)
-
Bita Moghaddam (Oregon Health and Science University, USA)
Catecholamines in Stress, Anxiety and Aversion
Discussion Leaders
-
Matthew Wanat (University of Texas at San Antonio, USA)
Speakers
-
Michael Bruchas (University of Washington, USA)
-
Joshua Johansen (RIKEN Brain Science Institute, Japan)
-
Zoe McElligott (University of North Carolina at Chapel Hill, USA)
-
Jose Moron-Concepcion (Washington University in St. Louis, USA)
Expanding Views of Dopamine in Learning
Discussion Leaders
-
Dave Lovinger (National Institute on Alcohol Abuse and Alcoholism, NIH, USA)
Speakers
-
Yoshi Aso (Janelia Research Campus, Howard Hughes Medical Institute, USA)
-
Sam Gershman (Harvard University, USA)
-
Jesse Goldberg (Cornell University, USA)
-
Geoffrey Schoenbaum (National Institute on Drug Abuse, NIH, USA)
-
Ilana Witten (Princeton University, USA)
Catecholamine Circuits, Learning and Attention
Discussion Leaders
-
Alexxai Kravitz (National Institute of Diabetes and Digestive and Kidney Diseases, NIH, USA)
Speakers
-
Michael Frank (Brown University, USA)
-
Mara Mather (University of Southern California, USA)
-
Vanessa Ruta (Rockefeller University, USA)
-
Saleem Nicola (Albert Einstein College of Medicine, USA)
Catecholamines in Addiction and Reward
Discussion Leaders
-
Robert Malenka (Stanford University School of Medicine, USA)
Speakers
-
Charlotte Boettiger (University of North Carolina at Chapel Hill, USA)
-
Antonello Bonci (National Institute on Drug Abuse, NIH, USA)
-
Stephanie Borgland (University of Calgary, Canada)
-
Nadia Chaudhri (Concordia University, Canada)
-
Philippe Faure (Université Pierre et Marie Curie, France)
-
Christian Luscher (University of Geneva, Switzerland)
Keynote Session: Dopamine Actions in the Striatum in Relation to Motivation and Addiction
Discussion Leaders
-
Patricia Janak (Johns Hopkins University, USA)
Speakers
-
Paul Phillips (University of Washington, USA)
